| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Abatacept treatment for patients with early active primary Sjögren's syndrome: a single-centre, randomised, double-blind, placebo-controlled, phase 3 trial (ASAP-III study)
|
van Nimwegen, Jolien F
|
|
|
2 |
3 |
p. e153-e163
|
artikel
|
| 2 |
Assessment of the anti-CD40 antibody iscalimab in patients with primary Sjögren's syndrome: a multicentre, randomised, double-blind, placebo-controlled, proof-of-concept study
|
Fisher, Benjamin A
|
|
|
2 |
3 |
p. e142-e152
|
artikel
|
| 3 |
Burden of osteoarthritis in China, 1990–2017: findings from the Global Burden of Disease Study 2017
|
Long, Huibin
|
|
|
2 |
3 |
p. e164-e172
|
artikel
|
| 4 |
Choosing a treatment: how can patients be guided through the labyrinth?
|
Spierings, Julia
|
|
|
2 |
3 |
p. e130-e131
|
artikel
|
| 5 |
High prevalence and burden of osteoarthritis in China
|
Wei, Jie
|
|
|
2 |
3 |
p. e127-e128
|
artikel
|
| 6 |
How can fatigue be addressed in individuals with systemic sclerosis?
|
Stamm, Tanja
|
|
|
2 |
3 |
p. e128-e129
|
artikel
|
| 7 |
Is it the end of the road for abatacept treatment in Sjögren's syndrome?
|
Fisher, Benjamin A
|
|
|
2 |
3 |
p. e125-e126
|
artikel
|
| 8 |
Oasis or mirage—a new drug shows promise for Sjögren's syndrome
|
Baer, Alan N
|
|
|
2 |
3 |
p. e123-e125
|
artikel
|
| 9 |
Randomised controlled trials in systemic sclerosis: patient selection and endpoints for next generation trials
|
Del Galdo, Francesco
|
|
|
2 |
3 |
p. e173-e184
|
artikel
|
| 10 |
Research in Brief
|
Thorley, Jennifer
|
|
|
2 |
3 |
p. e134
|
artikel
|
| 11 |
Tackling systemic sclerosis from all angles
|
The Lancet Rheumatology,
|
|
|
2 |
3 |
p. e121
|
artikel
|
| 12 |
The future of treatment in systemic sclerosis: can we design better trials?
|
Pope, Janet E
|
|
|
2 |
3 |
p. e185-e194
|
artikel
|
| 13 |
Tocilizumab in patients with anti-TNF refractory juvenile idiopathic arthritis-associated uveitis (APTITUDE): a multicentre, single-arm, phase 2 trial
|
Ramanan, Athimalaipet V
|
|
|
2 |
3 |
p. e135-e141
|
artikel
|
| 14 |
Tocilizumab in patients with juvenile idiopathic arthritis-associated uveitis
|
Quartier, Pierre
|
|
|
2 |
3 |
p. e122-e123
|
artikel
|
| 15 |
Treatment efficacy in secondary Raynaud's phenomenon
|
Pauling, John D
|
|
|
2 |
3 |
p. e132
|
artikel
|
| 16 |
Treatment efficacy in secondary Raynaud's phenomenon – Authors' reply
|
Roustit, Matthieu
|
|
|
2 |
3 |
p. e132-e133
|
artikel
|
Tijdschrift beschrijving